IS HBEAG LOSS ASSOCIATED WITH AN IMPROVED OUTCOME IN HEPATITIS B PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)?

被引：0

作者：

Fung, S. ^{[1
]}

Buti, M. ^{[2
]}

Gane, E. ^{[3
]}

Afdhal, N. ^{[4
]}

Flaherty, J. ^{[5
]}

Martins, E. ^{[5
]}

Bekele, N. ^{[5
]}

Bornstein, J. ^{[5
]}

Marcellin, P. ^{[6
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Vall dHebron Hosp Gen, Serv Med Interna Hepatol, Barcelona, Spain

[3] Auckland City Hosp, Auckland, New Zealand

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Gilead Sci Inc, Foster City, CA 94404 USA

[6] Hop Beaujon, Clichy, France

来源：

关键词：

D O I：

10.1016/S0168-8278(12)60521-2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

508

引用

页码：S200 / S200

页数：1